FDA 510(k)

Median LCS (nombre interno) / eyonis LCS (nombre comercial) (1.0)

N.º K: K251474 · 2026-02-06

Fecha de decisión2026-02-06

Código de productoQDQ

Comité asesorRA

DecisiónSubstantially Equivalent

Resumen del dispositivo

Median LCS (internal name) / eyonis LCS (trade name) (1.0) is the device name listed in this FDA 510(k) record. The listed applicant is Median Technologies. It received FDA 510(k) clearance on 2026-02-06 under 510(k) number K251474. The device is classified under product code QDQ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the Median LCS (internal name) / eyonis LCS (trade name) (1.0)?

Median LCS (internal name) / eyonis LCS (trade name) (1.0) is a medical device that received FDA 510(k) clearance on 2026-02-06. The listed applicant is Median Technologies. The 510(k) number is K251474.

When did Median LCS (internal name) / eyonis LCS (trade name) (1.0) receive FDA 510(k) clearance?

Median LCS (internal name) / eyonis LCS (trade name) (1.0) received FDA 510(k) clearance on 2026-02-06, under 510(k) number K251474.

Who is the listed applicant for Median LCS (internal name) / eyonis LCS (trade name) (1.0)?

The FDA 510(k) record lists Median Technologies as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Median LCS (internal name) / eyonis LCS (trade name) (1.0)?

The FDA product code for Median LCS (internal name) / eyonis LCS (trade name) (1.0) is QDQ.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Dispositivos relacionados (Código: QDQ)

K261517qCT Lung (v1.0)Qure.Ai Technologies Pvt. , Ltd.K260898Transpara (2.1.0)Screenpoint Medical B.V.K260086CadAI-B DxBeamWorks, Inc.K260303See-Mode Augmented Reporting Tool, Breast (SMART-B)See-Mode Technologies Pty, Ltd.K260714MammoScreen® (5)Therapixel K253825Saige-DxDeepHealth, Inc.

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.